Instead, the term «cane sugar» without any numerical data, was listed under «
non medicinal ingredients,» in compliance with the natural health products rules.
What — Where a patent «pertains» to an approved
medicinal ingredient for humans or animals (to be defined in subsequent regulations), a patentee can apply to the Minister of Health for an SPC to subsequently take effect on patent expiry.
In the Minister's view, a previously
approved medicinal ingredient (here an enantiomer) could never be an «innovative drug» regardless of the innovator's effort in developing the...
The Federal Court had found that that the object of the invention was to take advantage of the chemically stable characteristics of tenofovir and emtricitabine in combination and sometimes with a
third medicinal ingredient.
With the soothing power of Chamomile, this teething gel offers safe, effective and naturally -
derived medicinal ingredients for your baby to treat you both to a full night's rest.
It draws upon a medley of ultra-healing, energy - shifting, and
medicinal ingredients designed to support all realms of the self (body, mind, spirit) during the vulnerable, revealing, and sometimes - scary process that is transmutation.
Delivers dramatic results without
harsh medicinal ingredients that can irritate or overdry skin, and can be used every day as part of a beautifying and anti-aging skincare regimen.
Atelier Ayesha: The Alchemist of Dusk game features include: New story and cast of characters: Ayesha's mission is to find her younger sister, Nio, who went missing after she left home to
gather medicinal ingredients, and Ayesha will be supported and helped by those already close to her, as well as new friends she'll meet along the way.
The Minister found that «a patent containing claims for a formulation can not «match» the approved formulation unless both formulations explicitly contain all of the
same medicinal ingredients».
The Certificates of Supplementary Protection are available for both human use and veterinary
use medicinal ingredients but as of this time, no applications have been filed for veterinary use.
The «475 Patent claimed chemically stable characteristics of tenofovir and emtricitabine in combination and sometimes with a
third medicinal ingredient.
Additional Acquisitions African • Diviner's Slit Gong with Power Attachments, 19th — 20th century, Yaka culture (Democratic Republic of the Congo), wood, glass beads, mirror, coin, pigment fiber, cloth,
medicinal ingredients, 15 1/4» h. Adolph D. and Wilkins C. Williams Fund.
it pertains to
a medicinal ingredient, an SPC has not previously been granted in respect of the same first market authorization etc.).
Rights are granted «only with respect to the making, constructing, using and selling» of the approved drug containing
the medicinal ingredient, or combination of medicinal ingredients included in the SPC. Unapproved drugs are not protected.
The listing criteria require that to be eligible for listing the patent must contain, under section 4 (2)(a), «a claim for
the medicinal ingredient» or under section 4 (2)(b) «a claim for the formulation that contains the medicinal ingredient», in either case where the medicinal agreement or formulation had been approved through the issuance of an NOC in respect of the Submission.
The FCA rejected the argument that claims to a combination of
medicinal ingredients was a «formulation of the separate medicinal ingredients into the new combination product» as the definition of «formulation» in the PM (NOC) Regulations is clear and must contain both medicinal and non-medicinal ingredients.
The Minister found that
the medicinal ingredients claimed in the «475 Patent did not match up with those in the NDS.
In conclusion the FCA upheld the Judge's conclusion that the patent claims fail the requirement for product specificity because they do not make specific reference to
the medicinal ingredient rilpirivine, but only the broad class of compounds, but the FCA did so under section 4 (2)(a) rather than 4 (2)(b).
Here since the «475 Patent did not claim a formulation and only claimed
medicinal ingredients the «475 Patent should properly have been considered by the Minister or the Federal Court under section 4 (2)(a) which deals with claims to medicinal ingredients.
The Minister of Health refused to list the «475 Patent on the Patent Register as, in his view, it did not meet the requirements of section 4 (2)(b) that require that to be eligible for listing the patent must contain «a claim for the formulation that contains
the medicinal ingredient and the formulation has been approved through the issuance of a notice of compliance in respect of the Submission».
The NDS stated that the drug, known as Complera, contained
the medicinal ingredients: tenofovir, emtricitabine, and rilpivirine.
Sildenafil,
the medicinal ingredient in Viagra, was initially pursued for its use in treating hypertension and in 1998 Pfizer received a patent claiming sildenafil and its use in treating hypertension and angina.